Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001641172-25-025761
Filing Date
2025-08-28
Accepted
2025-08-28 09:10:54
Documents
3
Period of Report
2025-08-28

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 18076
2 EX-99.1 ex99-1.htm EX-99.1 16784
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2681
  Complete submission text file 0001641172-25-025761.txt   39843
Mailing Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544
Business Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544 603824911
CytoMed Therapeutics Ltd (Filer) CIK: 0001873093 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41677 | Film No.: 251267979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)